Nanobusiness News

RSS

Nanostart Takes Significant Ownership Position in BioMers

Nanostart AG has taken a significant ownership position in BioMers Pte Ltd, a Singapore-based medical technology company with a branch office in the U.S. The company is developing innovative new solutions for various bio...

From Coreo AG 17 Dec 2009

Angstron Materials Awarded Multi-Million Contract to Mass-Produce Nano Graphene Platelets

Angstron Materials Inc., a world leader in the production of nano graphene platelets (NGPs), has been awarded 1.494 million to develop processes for mass-producing chemically modified ("functionalized") NGPs for a nearly limitless number of applications in the aerospace, energy, defense, automotive and telecommunications markets.

17 Dec 2009

Funding Will Enhance Liquidia's PRINT Manufacturing Process

Liquidia Technologies, a privately-held nanotechnology company that develops and manufactures precisely engineered particles for improved delivery of biological and small molecule therapeutics, today announced it will re...

17 Dec 2009

Russian Corporation of Nanotechnologies Transfers Multi-Billion Rubles to Russian Federation

In accordance with the Decree of the Government of the Russian Federation No. 1455-r on the Return of Temporarily Free Funds of State Corporations to the Budget of the Russian Federation, RUSNANO, established in 2007 by the Federal law No. 139-FZ to enable Government policy in the field of Nanotechnology, transferred 66,4 billion rubles to the bank accounts of the Federal Treasury of the Russian Federation.

17 Dec 2009

DuPont Air Products NanoMaterials Non-Infringement Lawsuit Against Cabot Microelectronics

DuPont Air Products NanoMaterials L.L.C. (DA NanoMaterials) remains confident in its legal positions following the judge's order denying all summary judgment motions in DA NanoMaterials' patent invalidity/non-inf...

17 Dec 2009

New Systems Solution Capabilities will Enhance MEMSIC Worldwide Growth

MEMSIC, Inc, (NASDAQ GM: MEMS), a leading MEMS solution provider announced today the signing of an Asset Purchase Agreement with Crossbow Technology to acquire selected Crossbow Technology product lines. The purchase inc...

From MEMSIC Inc. 16 Dec 2009

Diverse Global Applications Expected for Automobiles, Aircraft, Buildings

Hitachi Chemical Co., Ltd. (Head Office: Tokyo; President and CEO: Kazuyuki Tanaka; Paid-in Capital: 15.5 billion yen, hereinafter "Hitachi Chemical") introduced the SPD (Suspended Particle Device) light-control film technology from New York based Research Frontiers Inc. (NASDAQ:REFR), and commercialized a roll-coated, wide-width SPD film whose light transmittance can be freely controlled by simply adjusting AC voltage.

16 Dec 2009

Nanophase Technologies Appoints New Vice President of Operations

Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in the development of advanced nanoengineered products, today announced the appointment of Glenn Judd to vice president of operations. In his pre...

From Nanophase Technologies Corporation 16 Dec 2009

WaferGen Biosystem Launches Human MicroRNA Panel for Service for Gene-Expression Profiling Using SmartChip

WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genetic analysis systems, today announced that it will be launching the Human MicroRNA Panel for its innovative service for ge...

From Takara Bio USA, Inc. 16 Dec 2009

Nanotherapeutics Acquires in Bankruptcy Proceedings Two Late Stage Clinical Programs

Nanotherapeutics, Inc., a privately held biopharmaceutical company, announced that it has acquired in bankruptcy proceedings two late stage clinical programs: Ramoplanin from Oscient Pharmaceuticals Corporation and PRX-3140 from EPIX Pharmaceuticals, Inc. Ramoplanin - an oral antibiotic for the treatment of Clostridium difficile-associated disease (CDAD) - is entering Phase 3 trials.

From Nanotherapeutics Inc. 16 Dec 2009